Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: L2007S....J3 will receive rights to use seven U.S. patents

You seem to be ignoring the points about the language used in the Verigy PR.  I'm not trying to pick a fight, but wondering why you are willing to ignore that "over 30 companies purchased licenses" language.

Share
New Message
Please login to post a reply